Promise and pitfalls of administrative data in evaluating pregnancy outcomes

被引：15

作者：

Andrews, Elizabeth B. ^{[1
]}

Tennis, Patricia ^{[1
]}

机构：

[1] RTI Hlth Solut, Res Triangle Pk, NC 27709 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2007年 / 16卷 / 11期

关键词：

D O I：

10.1002/pds.1499

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：1181 / 1183

页数：3

共 5 条

[1] Paroxetine in the first trimester and the prevalence of congenital malformations [J].

Cole, J. Alexander ;

Ephross, Sara A. ;

Cosmatos, Irene S. ;

Walker, Alexander M. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (10) :1075-1085

[2] Bupropion in pregnancy and the prevalence of congenital malformations [J].

Cole, J. Alexander ;

Modell, Jack G. ;

Haight, Barbara R. ;

Cosmatos, Irene S. ;

Stoler, Joan M. ;

Walker, Alexander M. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (05) :474-484

[3] Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy [J].

Davis, Robert L. ;

Rubanowice, David ;

McPhillips, Heather ;

Raebel, Marsha A. ;

Andrade, Susan E. ;

Smith, David ;

Yood, Marianne Ulcickas ;

Platt, Richard .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (10) :1086-1094

[4] First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects [J].

Louik, Carol ;

Lin, Angela E. ;

Werler, Martha M. ;

Hernandez-Diaz, Sonia ;

Mitchell, Allen A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (26) :2675-2683

[5]

*US DEP HHS FDA, 2002, GUID IND EST PREGN E

← 1 →